ST. PAUL, Minn.--(BUSINESS WIRE)--Mar. 13, 2015--
3M announced today that it has completed its acquisition of Ivera
Medical Corp., a manufacturer of health care products that disinfect and
protect devices used for access into a patient’s bloodstream. The
business is now a wholly owned subsidiary of 3M and a part of its
Critical & Chronic Care Solutions Division.
3M’s vascular access products play an important role in helping to
reduce complications for patients with I.V. catheters. The addition of
Ivera will enable 3M to bring a broader array of vascular access
solutions to more health care systems worldwide.
Ivera’s I.V. port connector caps, sold under the Curos® Brand, are used
to disinfect and act as a barrier to contamination on devices that
provide access to I.V. lines. These products complement 3M’s vascular
access products including Tegaderm™ CHG (Chlorhexidine Gluconate) I.V.
Securement Dressings, which deliver the critical elements of
antimicrobial protection and securement for I.V. site care.
Ivera is based in San Diego, Calif., employs approximately 60 people and
has annual sales of approximately $30 million.
3M is a science-based company with a culture of
creative collaboration that inspires powerful technologies, making life
better. With $32 billion in sales, 3M employs 90,000 people worldwide
and has operations in more than 70 countries. For more information,
or follow @3MNewsroom on Twitter.
3M, Tegaderm, and Curos are trademarks of 3M.
Lori Anderson, 651-733-0831
Aaron Berstler, 651-789-1264
Matt Ginter, 651-733-8206